scispace - formally typeset
A

A. C. S. A. Herrera

Researcher at Universidade Estadual de Londrina

Publications -  29
Citations -  886

A. C. S. A. Herrera is an academic researcher from Universidade Estadual de Londrina. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 15, co-authored 28 publications receiving 774 citations. Previous affiliations of A. C. S. A. Herrera include The Catholic University of America.

Papers
More filters
Journal ArticleDOI

Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy.

TL;DR: The results showed that advanced breast cancer diseased patients without previous chemotherapy presented anemia and high oxidative stress status characterized by elevated levels of lipid peroxidation and nitric oxide, and reduced catalase activity when compared with controls.
Journal ArticleDOI

Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer

TL;DR: The data obtained indicated that oxidative stress enhancement and immune response impairment may be necessary to ensure cancer progression to advanced stages and may result from both host and tumor inflammatory mediators.
Journal ArticleDOI

Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women.

TL;DR: Evaluated by sensitive methods the oxidant and antioxidant changes that develop after natural menopause, postmenopausalWomen demonstrated lower levels of oxidative damage and a higher antioxidant capacity than premenopausal women.
Journal ArticleDOI

Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients

TL;DR: The clinical importance of the findings lies in the fact that the inflammatory status varies in distinct ways due to molecular subtype of breast cancer, opening potential therapeutic targets to future therapies.
Journal ArticleDOI

Breast cancer in Brazil: epidemiology and treatment challenges.

TL;DR: There is a need for identifying and discussing which factors have substantially contributed to this growing number of cases in Brazil, including access to treatment, prevention and early diagnosis, weaknesses of the local health policy, and intrinsic genetic peculiarities of the Brazilian population.